Stockreport

Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit

Xilio Therapeutics, Inc.  (XLO) 
PDF WALTHAM, Mass., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies [Read more]